19-11120162-T-G

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP1_StrongPM5PM2PP4

This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1916T>G (p.Val639Gly) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PP1_Strong, PM2, PM5 and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025.The supporting evidence is as follows:PM2: PopMax MAF = 0.00002196 (0.002196%) in South Asian exomes+genomes (gnomAD v4.1.0).PM5: 1 other missense variant in the same codon is classified as Pathogenic by these guidelines:- NM_000527.5(LDLR):c.1916T>A (p.Val639Asp) (ClinVar ID 200922). PP4: Variant meets PM2 and is identified in only 1 proband with MEDPED criteria for FH from Pakistan (PMID 22311046 – Ahmed et al., 2012), after alternative causes of high cholesterol were excluded.PP1_Strong: Variant segregates with FH phenotype in 9 informative meiosis from 1 family from Pakistan (PMID 22311046 – Ahmed et al., 2012): 6 affected family members have the variant and 3 unaffected family members do not have the variant. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10585680/MONDO:0007750/013

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

LDLR
NM_000527.5 missense

Scores

9
3
6

Clinical Significance

Likely pathogenic reviewed by expert panel P:2

Conservation

PhyloP100: 7.85

Publications

11 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM5
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDLRNM_000527.5 linkc.1916T>G p.Val639Gly missense_variant Exon 13 of 18 ENST00000558518.6 NP_000518.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDLRENST00000558518.6 linkc.1916T>G p.Val639Gly missense_variant Exon 13 of 18 1 NM_000527.5 ENSP00000454071.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461704
Hom.:
0
Cov.:
33
AF XY:
0.00000275
AC XY:
2
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111832
Other (OTH)
AF:
0.00
AC:
0
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Pathogenic:2
Jan 31, 2025
ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel
Significance:Likely pathogenic
Review Status:reviewed by expert panel
Collection Method:curation

The NM_000527.5(LDLR):c.1916T>G (p.Val639Gly) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PP1_Strong, PM2, PM5 and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025. The supporting evidence is as follows: PM2: PopMax MAF = 0.00002196 (0.002196%) in South Asian exomes+genomes (gnomAD v4.1.0). PM5: 1 other missense variant in the same codon is classified as Pathogenic by these guidelines: - NM_000527.5(LDLR):c.1916T>A (p.Val639Asp) (ClinVar ID 200922). PP4: Variant meets PM2 and is identified in only 1 proband with MEDPED criteria for FH from Pakistan (PMID 22311046 – Ahmed et al., 2012), after alternative causes of high cholesterol were excluded. PP1_Strong: Variant segregates with FH phenotype in 9 informative meiosis from 1 family from Pakistan (PMID 22311046 – Ahmed et al., 2012): 6 affected family members have the variant and 3 unaffected family members do not have the variant.

Mar 25, 2016
LDLR-LOVD, British Heart Foundation
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:literature only

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Pathogenic
0.38
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.89
D;.;.;.;.;.
Eigen
Benign
0.12
Eigen_PC
Benign
0.081
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.75
T;T;T;T;T;T
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.5
M;.;.;.;.;M
PhyloP100
7.8
PrimateAI
Benign
0.29
T
PROVEAN
Pathogenic
-6.3
D;D;D;D;D;D
REVEL
Benign
0.0
Sift
Uncertain
0.0010
D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D
Vest4
0.51
ClinPred
0.98
D
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.83
gMVP
0.96
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs794728584; hg19: chr19-11230838; COSMIC: COSV108047589; API